This fifth and final panel with Sean Bartholomew (Biopharma Applications Engineer, Germfree) and Grayson Heller (COO, cGMPnow) discuss the considerations for decentralized cell therapy manufacturing. The key points include the importance of designing identical and cloned processes, focusing on a copy-paste model for multiple locations.